Your browser doesn't support javascript.
loading
Efficacy and feasibility of sorafenib as a maintenance agent after allogeneic hematopoietic stem cell transplantation for Fms-like tyrosine kinase 3-mutated acute myeloid leukemia.
Battipaglia, Giorgia; Ruggeri, Annalisa; Massoud, Radwan; El Cheikh, Jean; Jestin, Matthieu; Antar, Ahmad; Ahmed, Syed Osman; Rasheed, Walid; Shaheen, Marwan; Belhocine, Ramdane; Brissot, Eolia; Dulery, Remy; Eder, Sandra; Giannotti, Federica; Isnard, Francoise; Lapusan, Simona; Rubio, Marie-Therese; Vekhoff, Anne; Aljurf, Mahmoud; Legrand, Ollivier; Mohty, Mohamad; Bazarbachi, Ali.
Afiliação
  • Battipaglia G; Hematology and Cellular Therapy Service, Saint Antoine Hospital, AP-HP, Paris, France.
  • Ruggeri A; Department of Hematology and Marrow Transplantation, Federico II University, Naples, Italy.
  • Massoud R; Hematology and Cellular Therapy Service, Saint Antoine Hospital, AP-HP, Paris, France.
  • El Cheikh J; Bone Marrow Transplantation Program, Department of Internal Medicine, American Universit6y of Beirut Medical Center, Beirut, Lebanon.
  • Jestin M; Bone Marrow Transplantation Program, Department of Internal Medicine, American Universit6y of Beirut Medical Center, Beirut, Lebanon.
  • Antar A; Hematology and Cellular Therapy Service, Saint Antoine Hospital, AP-HP, Paris, France.
  • Ahmed SO; Bone Marrow Transplantation Program, Department of Internal Medicine, American Universit6y of Beirut Medical Center, Beirut, Lebanon.
  • Rasheed W; Adult Hematology/HSCT Section, Oncology Center, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
  • Shaheen M; Adult Hematology/HSCT Section, Oncology Center, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
  • Belhocine R; Adult Hematology/HSCT Section, Oncology Center, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
  • Brissot E; Hematology and Cellular Therapy Service, Saint Antoine Hospital, AP-HP, Paris, France.
  • Dulery R; Hematology and Cellular Therapy Service, Saint Antoine Hospital, AP-HP, Paris, France.
  • Eder S; Hematology and Cellular Therapy Service, Saint Antoine Hospital, AP-HP, Paris, France.
  • Giannotti F; Hematology and Cellular Therapy Service, Saint Antoine Hospital, AP-HP, Paris, France.
  • Isnard F; Hematology and Cellular Therapy Service, Saint Antoine Hospital, AP-HP, Paris, France.
  • Lapusan S; Hematology and Cellular Therapy Service, Saint Antoine Hospital, AP-HP, Paris, France.
  • Rubio MT; Hematology and Cellular Therapy Service, Saint Antoine Hospital, AP-HP, Paris, France.
  • Vekhoff A; Hematology and Cellular Therapy Service, Saint Antoine Hospital, AP-HP, Paris, France.
  • Aljurf M; Hematology and Cellular Therapy Service, Saint Antoine Hospital, AP-HP, Paris, France.
  • Legrand O; Adult Hematology/HSCT Section, Oncology Center, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
  • Mohty M; Hematology and Cellular Therapy Service, Saint Antoine Hospital, AP-HP, Paris, France.
  • Bazarbachi A; Hematology and Cellular Therapy Service, Saint Antoine Hospital, AP-HP, Paris, France.
Cancer ; 123(15): 2867-2874, 2017 Aug 01.
Article em En | MEDLINE | ID: mdl-28387928

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Leucemia Mieloide Aguda / Niacinamida / Transplante de Células-Tronco Hematopoéticas / Antineoplásicos Tipo de estudo: Observational_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Ano de publicação: 2017 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Leucemia Mieloide Aguda / Niacinamida / Transplante de Células-Tronco Hematopoéticas / Antineoplásicos Tipo de estudo: Observational_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Ano de publicação: 2017 Tipo de documento: Article País de afiliação: França